BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
113.54
0.84 (0.75%)
At close: Aug 15, 2025, 3:59 PM
113.81
0.24%
After-hours: Aug 15, 2025, 07:27 PM EDT

BioNTech SE Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.73B 2.74B 3.03B 2.69B 2.73B 3.82B 6.62B 9.18B 12.21B 17.31B 18.56B 21.19B 23.3B 18.98B 13.79B 7.77B 2.5B
Cost of Revenue
563.91M 539.21M 474.81M 958M 1.43B 1.81B 2.32B 2.75B 3.38B 4.53B 4.69B 5.07B 4.99B 3.64B 3.09B 1.85B 866.5M
Gross Profit
2.17B 2.2B 2.55B 1.73B 1.3B 2.01B 4.3B 6.43B 8.83B 12.78B 13.87B 16.12B 18.31B 15.33B 10.7B 5.92B 1.64B
Operating Income
-1.08B -1.05B -673.54M -610.94M -471.2M 690.4M 3.46B 5.77B 8.54B 12.64B 14.05B 16.39B 18.37B 15.28B 10.83B 5.92B 1.64B
Interest Income
446.5M 504M 624.4M 624.5M 609.2M 489.2M 407.6M 259M 108.1M 48.5M 10M 2.9M 1.7M 1.5M 1.2M 1.08M 975.01K
Pretax Income
-797.49M -683.89M -321.89M -251.08M 146.6M 1.19B 3.7B 5.91B 8.64B 12.95B 14.5B 16.72B 18.42B 15.05B 10.54B 5.66B 1.55B
Net Income
-772.73M -672.03M -473.63M -508.49M 113M 930.3M 2.75B 4.38B 6.24B 9.43B 10.32B 11.75B 12.86B 10.29B 7.49B 4.07B 1.2B
Selling & General & Admin
587.93M 599.93M 617.23M 617.53M 573.6M 572.6M 560.7M 563.7M 571M 544.5M 552.9M 476M 387.7M 330.2M 219.96M 170.66M 131.1M
Research & Development
2.27B 2.25B 2.22B 2.19B 1.97B 1.79B 1.7B 1.54B 1.57B 1.53B 1.32B 1.23B 1.02B 950.72M 936.75M 904.05M 798.14M
Other Expenses
395.5M 404.2M 396.7M 42.1M 42.1M 32.9M 141M 132.7M 94.9M 102.9M -92.1M -363.7M -527.2M -591.6M -1.04B -991.75M -884.04M
Operating Expenses
3.26B 3.27B 3.16B 2.26B 1.68B 1.15B 758.5M 750.3M 665.9M 647.4M 460.8M 372.7M 322M 416.3M 121.06M 82.95M 45.21M
Interest Expense
49.2M 20M 38.9M 32.9M 26.9M 123.7M 106.9M 109.2M 113.7M 16.3M 17.6M 14.1M 187.13M 183.73M 180.43M 201.26M 32.01M
Selling & Marketing Expenses
66M 67.9M 64.6M 60.9M 66.1M 62.7M 59.3M 57.7M 57.4M 59.5M 62.8M 60.5M 56M 50.4M 39.2M 32.97M 22.73M
Cost & Expenses
3.82B 3.8B 3.64B 3.22B 3.12B 2.97B 3.08B 3.5B 4.05B 5.18B 5.15B 5.44B 5.31B 4.06B 3.21B 1.93B 911.7M
Income Tax Expense
-24.76M -11.96M 151.64M 257.31M 33.5M 255.8M 944.4M 1.54B 2.41B 3.52B 4.17B 4.97B 5.56B 4.75B 3.04B 1.59B 353.19M
Shares Outstanding (Basic)
240.35M 240.28M 239.74M 237.73M 240.53M 237.73M 239.7M 239.77M 242.61M 242.93M 255.72M 259.22M 259.75M 244.47M 244.37M 244.06M 243.13M
Shares Outstanding (Diluted)
240.35M 240.28M 244.57M 237.73M 240.53M 241M 239.7M 239.77M 244.98M 246.08M 255.72M 259.22M 259.75M 259.75M 260M 258.79M 256.97M
EPS (Basic)
-3.24 -2.82 -2.02 -2.16 0.47 3.83 10.89 17.18 24.42 36.61 40.62 46.78 51.75 42.15 30.74 16.72 4.92
EPS (Diluted)
-3.26 -2.84 -2.08 -2.2 0.43 3.77 10.76 17.05 24.29 36.50 39.86 45.23 49.55 39.70 29.05 15.83 4.68
EBITDA
-429.2M -351M -376.19M -308.71M 65.51M 1.17B 4.07B 5.76B 7.87B 12.18B 13.59B 16.17B 18.73B 15.24B 10.67B 5.94B 1.58B
EBIT
-744.3M -661.83M -295.74M -226.37M 162.14M 1.23B 3.74B 5.95B 8.68B 13.04B 14.61B 16.83B 18.77B 15.32B 10.76B 5.91B 1.55B
Depreciation & Amortization
302.75M 298.48M 166.68M 164.78M 146.46M 139.02M 133.06M 124.97M 126.85M 123.75M 122.25M 108M 90.95M 76.3M 62.69M 51.34M 43.46M